At 12 months in a phase 1/2 trial, the Bimatoprost Drug Pad-IOL System improved IOP, vision and treatment burden in patients ...

At Vision Expo, the company behind the Heru Prime virtual reality headset for vision care pretesting showcased an upgrade ...

Some chronic diseases disproportionately affect Hispanic, Latino and African American people, and optometrists can better ...

Presentations among children with multiple food allergies vary by allergen combination, indicating distinct phenotypes, according to a poster presented at the American Academy of Allergy, Asthma & ...

A 16-year-old female high school junior with a history of recurrent patellar instability presented with left knee pain following a patellar dislocation event.Two weeks earlier, she stepped onto a ...

The FDA approved secukimumab for children aged 12 years and older with moderate to severe hidradenitis suppurativa, Novartis announced in a press release.The approval makes secukinumab (Cosentyx) the ...

Dyslipidemia is highly prevalent and the primary direct driver of atherosclerotic CVD. In the more than 7 years since the last American Heart Association/American College of Cardiology/Multisociety ...

An updated guideline for the management of dyslipidemia emphasized enhancing health-related behaviors and consideration of early initiation of lipid-lowering therapy, even in adults as young as 30 ...

In this video from the Macula Society meeting, Theodore Leng, MD, FACS, discusses 5-year data on pegcetacoplan, from Apellis, for geographic atrophy.“This presentation really supported the notion that ...

A new clinical delivery model offers resources to help health care providers, or HCPs, become more culturally competent and improve health outcomes for their Black patients, an expert said.BlackDoctor ...

Please provide your email address to receive an email when new articles are posted on . More than 30 cases of TMVII were recently reported in Minnesota. The infection can mimic eczema, psoriasis and ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...